AstraZeneca Pharma India dropped 13.11% to Rs 5,713.15 after the company’s consolidated net profit tumbled 46.08% to Rs 15.80 crore in Q3 FY24 as compared with Rs 29.30 crore in Q3 FY23.
| Subscribe To Our Free Newsletter |
The Most Valuable Commodity Is Information!
